160 HEALTH (02656) surged more than 10% again, reaching a new all-time high of HK$140.5. The stock has almost doubled in value since its inclusion on March 9. Just one month ago, on February 11, the stock experienced a sharp single-day drop of approximately 30%. At the time of writing, the stock was up 10.17% to HK$139.7, with a turnover of HK$127 million.

Regarding recent developments, 160 HEALTH recently announced that its Board of Directors reported positive progress in the Group's digital medical health solutions business up to December 31, 2025. In the 2025 fiscal year, the Group established operational cooperation for its "160AI Hospital" initiative with 82 public Class II Grade A and above hospitals, representing an increase of over 720% compared to 2024. Notably, 52 new cooperative public hospitals were added in the fourth quarter of 2025 alone, achieving a quarter-on-quarter growth of 420%.

Previously, 160 HEALTH also announced that, leveraging its integrated model of "Platform + AI Agents + Operations," it is progressively deploying a "Medical Digital Employee" system for medical institutions. This initiative is promoting the implementation of AI agents, represented by OpenClaw, in medical scenarios.

It is also noteworthy that 160 HEALTH will face its first share lock-up expiration next week. According to a prior announcement, the share unlock for Luo Holdings Limited (holding 30.59%) will be conducted in two phases: the first phase unlock deadline is March 16, 2026, and the final unlock date for the second phase is September 16, 2026.